Literature DB >> 20621145

Role of central NO-cGMP pathway in vasopressin and oxytocin gene expression during sepsis.

Gabriela Ravanelli Oliveira-Pelegrin1, Fábio Alves Aguila, Paulo José Basso, Maria José Alves Rocha.   

Abstract

Sepsis induces massive production of inflammatory mediators, such as nitric oxide (NO), and causes neuroendocrine and cardiovascular alterations. This study investigates the involvement of the central NO-cGMP pathway in arginine vasopressin (AVP) and oxytocin (OXY) gene expression during sepsis induced by cecal ligation and puncture (CLP). Male Wistar rats received an i.c.v. injection of ODQ (0.25 μg/μL), a selective inhibitor of the heme site of soluble guanylate cyclase, or of 1% dymethilsulfoxide (DMSO), as vehicle. Thirty minutes after the injections, sepsis was induced by cecal ligation and puncture or the animals were sham operated. The ODQ pre-treatment did not alter the progressive NO increase observed after CLP. In the supraoptic nucleus (SON), this pretreatment increased the relative gene expression ratio of AVP and OXY in the initial phase of sepsis, but in the late phase, the gene expression of both hormones was reduced. In the paraventricular nucleus (PVN), soluble guanylate cyclase inhibition caused an even larger decrease in the relative gene expression ratio of AVP and OXY during sepsis. These results are indicative of a role of the NO-cGMP pathway in hormonal synthesis in the SON and PVN of the hypothalamus during polymicrobial sepsis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621145     DOI: 10.1016/j.peptides.2010.06.031

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Neuropeptide downregulation in sepsis.

Authors:  Fabiano Pinheiro da Silva; Marcel Cerqueira César Machado; Paulo Clemente Sallet; Fernando Godinho Zampieri; Alessandra Carvalho Goulart; Francisco Torggler Filho; Hermes Vieira Barbeiro; Irineu Tadeu Velasco; Luiz Monteiro da Cruz Neto; Heraldo Possolo de Souza
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

2.  Inhibition of neuronal nitric oxide synthase activity does not alter vasopressin secretion in septic rats.

Authors:  Camila Henriques Coelho; Thalita Freitas Martins; Gabriela Ravanelli Oliveira-Pelegrin; Maria José Alves da Rocha
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

3.  Interleukin-1 receptor antagonist decreases cerebrospinal fluid nitric oxide levels and increases vasopressin secretion in the late phase of sepsis in rats.

Authors:  Fazal Wahab; Lucas F Tazinafo; Evelin C Cárnio; Fábio A Aguila; Marcelo E Batalhão; Maria José A Rocha
Journal:  Endocrine       Date:  2014-10-22       Impact factor: 3.633

4.  Impairment of osmotic challenge-induced neurohypophyseal hormones secretion in sepsis survivor rats.

Authors:  Nilton Nascimento Santos-Junior; Luís Henrique Angenendt Costa; Carlos Henrique Rocha Catalão; Alexandre Kanashiro; Tarek Sharshar; Maria José Alves Rocha
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

5.  Interleukin-1 Receptor Antagonist Decreases Hypothalamic Oxidative Stress During Experimental Sepsis.

Authors:  Fazal Wahab; Nilton N Santos-Junior; Rodrigo Pereira de Almeida Rodrigues; Luis Henrique A Costa; Carlos Henrique R Catalão; Maria Jose A Rocha
Journal:  Mol Neurobiol       Date:  2015-07-17       Impact factor: 5.590

6.  Stimulation of brain nicotinic acetylcholine receptors activates adrenomedullary outflow via brain inducible NO synthase-mediated S-nitrosylation.

Authors:  Youichirou Higashi; Takahiro Shimizu; Masaki Yamamoto; Kenjiro Tanaka; Toshio Yawata; Shogo Shimizu; Suo Zou; Tetsuya Ueba; Kazunari Yuri; Motoaki Saito
Journal:  Br J Pharmacol       Date:  2018-08-12       Impact factor: 8.739

7.  Curcumin suppresses inflammatory cytokines and heat shock protein 70 release and improves metabolic parameters during experimental sepsis.

Authors:  Letycia Silvano da Silva; Carlos Henrique Rocha Catalão; Tatiana Tocchini Felippotti; Gabriela Ravanelli de Oliveira-Pelegrin; Sérgio Petenusci; Luis Alexandre Pedro de Freitas; Maria José Alves Rocha
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.